Literature DB >> 17446499

Directionality in drug action on sodium-calcium exchange.

D Noble1, M P Blaustein.   

Abstract

In pathological conditions, the exchanger may generate deleterious calcium entry. A drug that inhibited calcium entry, while still allowing transport of calcium out of the cell would then seem attractive. In fact, this is impossible for thermodynamic reasons. Inhibitors may appear to be more effective when the exchanger is operating in net calcium entry mode than in calcium exit mode. This is, however, always attributable to differences in conditions because there is strong internal sodium dependence of drug action on the exchanger. When the exchanger is operating near equilibrium, drug action is found to be equally effective in both directions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446499     DOI: 10.1196/annals.1387.013

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Direct Loading of the purified endogenous inhibitor into the cytoplasm of patched cardiomyocytes blocks the ion currents and calcium transport through the NCX1 protein.

Authors:  Liron Boyman; Reuben Hiller; W Jonathan Lederer; Daniel Khananshvili
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

Review 2.  Regulation of intracellular and mitochondrial sodium in health and disease.

Authors:  Elizabeth Murphy; David A Eisner
Journal:  Circ Res       Date:  2009-02-13       Impact factor: 17.367

Review 3.  The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.

Authors:  Mordecai P Blaustein; Jin Zhang; Ling Chen; Hong Song; Hema Raina; Stephen P Kinsey; Michelle Izuka; Takahiro Iwamoto; Michael I Kotlikoff; Jerry B Lingrel; Kenneth D Philipson; W Gil Wier; John M Hamlyn
Journal:  Hypertension       Date:  2008-12-22       Impact factor: 10.190

4.  Conditional knockout of smooth muscle sodium calcium exchanger type-1 lowers blood pressure and attenuates Angiotensin II-salt hypertension.

Authors:  Youhua Wang; Ling Chen; Meng Li; Helen Cha; Takahiro Iwamoto; Jin Zhang
Journal:  Physiol Rep       Date:  2015-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.